Navigation Links
Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
Date:10/7/2008

LAKE FOREST, Ill., Oct. 7 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its third-quarter 2008 results on Wednesday, Nov. 5, 2008, at 8 a.m. Central time.

The company will release its third-quarter results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call will be available on Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available on the Hospira Web site for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
2. Hospira Expands Board of Directors
3. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
4. Biogenerics Will Save Billions, Says Hospira CEO
5. Abbott Hosts Conference Call for Third-Quarter Earnings
6. Symbiotic microbes induce profound genetic changes in their hosts
7. Frankfurt Hosts Continuing Growth of CMPi Pharma Events
8. Pharsight Hosts European PKS User Meeting
9. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
10. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
11. Germany Hosts World Leading Medical Industry Fair

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ENHAGEN, Dec. 2 The world,s first ...e technology, a breakthrough alternative to replac...ufacture of synthetic rubber with renewable biomas...eek. One tire will be on display at a lounge in th...ional Airport throughout December 21, while the ot...
(Date:12/2/2009)... LELYSTAD, The Netherlands, December 2 /PRNewswire...technology company focusing on protein mimicking,t...s today announced that it,has appointed Wim E.M. M... Dr. Mol will be responsible for all of Pepscans...d strategic direction of the company. He brings to...
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/...ompany") (OTC Bulletin Board: EMDY), a leading,pro...mula, milk powder and,soybean products in China, t...n the Spring issue of US Food & Drink Executiv...250,000 executives in the food and beverage indust...
(Date:12/2/2009)... The Scientist, a leading scientific maga...cs’ Evolve “Intelligent” EMCCD c...Top 10 Innovations of 2009. , ...e; EMCCD camera from Photometrics ®, a desig...MCCD cameras for the life sciences, was ranked fou...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...USALEM and NEEDHAM, Massachusetts, December 10 /PR...wiss Exchange: ORIDN) today announced that,three s...be presented at the,upcoming AARC (American Associ...alifornia. These studies confirm the clinical bene...dion Microstream(R) capnography technology,and cle...
...SANNE, Switzerland, December 10 Diagnoplex, a,dev...nced the closing of a,Series A financing raising C...y Novartis Venture Fund and NeoMed, with Initiativ...rtis Venture Fund was also a seed investor in the,...stors and BMP Associés,acted as counsel to the co...
...MOUTH, Minn., Dec. 9 ev3 Inc. (Nasdaq: EVVV ),a...ay that it has received,510(k) clearance from the ...t its,EverCross 0.035" and NanoCross 0.014" periph...o begin full commercialization of the EverCross an...in January 2009. , Robert Palmisano, ev3,s presi...
Other Biology Technology:Oridion Announces Significant Medical Research to be Presented at AARC Congress 2Oridion Announces Significant Medical Research to be Presented at AARC Congress 3Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 2Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 3ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 3
(Date:12/2/2009)...tudy results strengthen the evidence that people w...e an increased risk for developing colorectal canc..., "This provides one more reason not to smoke, o... Michael J. Thun, M.D., M.S., vice president emeri... American Cancer Society. "Colorectal cancer shoul...
(Date:12/2/2009)...ce of a cancer-free status did not prompt people p...y (CT) lung-cancer screening program to pick up th... published in Cancer Epidemiology, Biomarkers & P...for Cancer Research. The December issue contains a...ld negate widespread concern in the lung screening...
(Date:12/2/2009)...iversity Medical Center researchers have figured o...ioma may be better able to resist radiation therap...g pathway in these cancer stem cells, they were ab...n a laboratory experiment. , The work builds of...ells resist the effects of radiation much better t...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 1Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 3Silenced genes as a warning sign of blood cancer 53655 1Silenced genes as a warning sign of blood cancer 53655 2Nanotechnology Transforms Pain Relief 53652 1Nanotechnology Transforms Pain Relief 53652 2Nanotechnology Transforms Pain Relief 53652 3Nanotechnology Transforms Pain Relief 53652 4
...om The Wistar Institute in Philadelphia and The Vi...mechanism involved in normal repression of the p53...le for the control of cancer in humans. , The new... intriguing approaches to diagnosing or intervenin...port on the team,s findings will be published onli...
...ervational study by researchers at the University ...n between 65 and 80 years of age who received trea...ived significantly longer than men who did not rec... December 13th issue of the Journal of the America...revention education and the resulting wide-spread ...
...mazing protein-making parts out of cells and putti...eins for a wide variety of medical uses. At the an...) Sept. 13 in San Francisco, Stanford engineering ...ch "cell-free" protein synthesis, including produc...n act as delivery trucks for a new class of potent...
Other Biology News:Novel regulatory mechanism identified for key tumor suppressor p53 2Novel regulatory mechanism identified for key tumor suppressor p53 3Older men treated for early prostate cancer live longer than those who are not 2Engineer ramps up protein production, develops versatile viral spheres 2Engineer ramps up protein production, develops versatile viral spheres 3
Goat Anti-Human Contactin-2 Polyclonal Antibodies, from R&D Systems
Human BMP 2 ELISA construction Kit from Antigenix America Inc.
... 120 utilizies CTI Molecular Imaging's proprietary... retaining the same imaging volume as the R4. The... of any commerically avaiable PET scanner. Focus ...on of any scinitallor based PETsystems. The combi...
...duct has been developed to significantly increase ...ins. Stability is increased at room temperature s...This product is subjected to 0.45 micron filtratio...tion insures consistently high levels of activity ...
Biology Products: